,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-04-26 05:59:00,U.S. stocks were expected to open higher but surrendered some of their earlier gains after March durable goods orders came in below consensus estimates.,0.09735621511936188,0.8681588172912598,0.03448500484228134,negative,-0.7708026170730591
1,2016-04-26 05:59:00,"Orders for long-lasting goods increased 0.8% last month, half of what Wall Street was expecting.",0.9527523517608643,0.024838224053382874,0.022409429773688316,positive,0.9279141426086426
2,2016-04-26 05:59:00,"And excluding transportation orders, durable goods orders fell 0.2%, missing the consensus estimate for a gain of 0.5%.",0.02132631465792656,0.9696584343910217,0.009015263058245182,negative,-0.9483321309089661
3,2016-04-26 05:59:00,"Besides this morning's flood of economic data, Wall Street was also bracing for more corporate earnings, as well as tomorrow's conclusion of the Federal Open Market Committee meeting.",0.33091220259666443,0.04427958279848099,0.6248082518577576,neutral,0.28663262724876404
4,2016-04-26 05:59:00,"Quarterly results were mostly upbeat led by results from 3M ( MMM ), Proctor & Gamble ( PG ) and Coach ( COH ).",0.7972775101661682,0.051004860550165176,0.15171760320663452,positive,0.746272623538971
5,2016-04-26 05:59:00,"Eli Lilly ( LLY ), Spirit Airlines ( SAVE ) and Whirlpool (WHR) reported mixed quarterly results.",0.016655493527650833,0.9512069225311279,0.032137662172317505,negative,-0.9345514178276062
6,2016-04-26 05:59:00,"Tuesday's remaining economic data includes the February Case Shiller home price index (expected +0.7%), the preliminary April purchasing managers index for the services sector (expected to increase to 52.3), the April consumer confidence index (exp 96.0 from 96.2), and the Richmond Fed manufacturing index (exp 12.0 from 22.0 in March).",0.3176688551902771,0.05211169645190239,0.6302194595336914,neutral,0.2655571699142456
7,2016-04-26 05:59:00,"(+) PETX (+13.17%) Announced a deal with Eli Lilly ( LLY ) to develop, market and commercialize Aratana's Galliprant

(-) SRPT (-47.16%) Federal advisory panel voted that Duchenne muscular dystrophy drug Eteplirsen was not effective

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.01245980616658926,0.038953471928834915,0.948586642742157,neutral,-0.02649366483092308
8,2016-04-26 05:59:00,Copyright (C) 2016 MTNewswires.com.,0.010173643939197063,0.017617104575037956,0.9722092151641846,neutral,-0.007443460635840893
9,2016-04-26 05:59:00,All rights reserved.,0.01556148286908865,0.01622452400624752,0.9682139754295349,neutral,-0.0006630411371588707
10,2016-04-26 05:59:00,Unauthorized reproduction is strictly prohibited.,0.014759602025151253,0.054922934621572495,0.9303174018859863,neutral,-0.04016333073377609
